688131 皓元医药
2025/03 - 三个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(32,502)381,960(63,606)(240,233)57,835
投资活动产生之现金流量净额63,037(783,654)(328,511)(713,002)(305,839)
筹资活动产生之现金流量净额154,933791,479409,209360,3241,007,294
汇率变动对现金及现金等价物的影响8,1357,8453,11114,415(7,242)
现金及现金等价物净增加/(减少)193,603397,63020,202(578,496)752,047
期初现金及现金等价物余额873,096475,466455,2641,033,760281,713
期末现金及现金等价物余额1,066,699873,096475,466455,2641,033,760